Basic Trial Information
Trial Description
Summary
Further Trial Information
Eligibility Criteria
Trial Contact Information
| Phase | Type | Status | Age | Sponsor | Protocol IDs |
|---|---|---|---|---|---|
| No phase specified | Health services research, Natural history/Epidemiology | Active | No age specified | Other | 2005-0518 NCT00507572 |
Summary
The goal of this research study is to collect information on patients who are or were pregnant while diagnosed with cancer and to store this information in a research database.
Further Study Information
If you agree to take part in this study, information about the type of cancer, the type of treatment you have had or are having, and details about your pregnancy will be collected for the database. Data will be collected from patients seen at MD Anderson since September 2003 until data has been collected for 500 cases. This information will serve as a basis for future studies about pregnant women with cancer. You will receive no special tests or treatment at MD Anderson as a result of this study.
Progress notes and ultrasound reports about your pregnancy will be requested from Maternal Fetal Medicine and/or from your personal obstetrician. This information will be entered into the database and also included in your medical record. If the information is not consistent in the record, we may contact you to clarify the information. You will remain on study until your pregnancy and/or any treatment you are receiving are completed.
Periodically the database will be updated to include information about patient survival. This information is usually found in the medical record however it may be necessary to contact you directly.
This is an investigational study. About 500 patients will take part in this study. All will be enrolled at MD Anderson.
Eligibility Criteria
Inclusion Criteria:
1. All pregnant patients with cancer and patients known to have been pregnant with a diagnosis of cancer are eligible, regardless of their diagnosis or treatment plan.
2. Patients may receive prenatal care from any obstetrician, but a consult with a Maternal Fetal Medicine physician is encouraged.
Exclusion Criteria:
N/A
Trial Lead Organizations/Sponsors
M. D. Anderson Cancer Center at University of Texas
| Andrea Milbourne, MD |  | Principal Investigator |
| Sue Rimes, RN | | Ph: 713-563-4546 |
Trial Sites
|
|
|
|
| U.S.A. | |||
|
|||
| Texas | |||
|
|||
| Houston | |||
|
|||
| M. D. Anderson Cancer Center at University of Texas | |||
| Andrea Milbourne, MD | Principal Investigator | ||
Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00507572
Information obtained from ClinicalTrials.gov on February 21, 2013
Back to Top
